Core Viewpoint - The article highlights the innovative strategies and cultural heritage techniques employed by Guilin Sanjin during the 14th Five-Year Plan period, emphasizing the company's commitment to quality and market expansion in the traditional Chinese medicine sector [2][13]. Group 1: Heritage Techniques Empowering Products - Guilin Sanjin's flagship product, Sanjin Watermelon Frost, has a history of over 200 years, with its modern production techniques improving upon traditional methods to achieve industrial-scale production [4][5]. - The company has successfully integrated modern Chinese medicine theories with traditional craftsmanship, resulting in high-purity products with reduced production cycles and no pollution [5]. - The "Guilin Sanjin Watermelon Frost Production Technique" was included in the Guilin Intangible Cultural Heritage List in 2024, showcasing the company's dedication to preserving and innovating traditional practices [5]. Group 2: Market Strategy and Consumer Focus - The company adopts a "thin profit margin, high sales volume" strategy, ensuring affordable pricing for consumers, with retail prices for Sanjin Watermelon Frost products ranging from a few to several tens of yuan [7]. - Over 90% of pharmacies in China carry Sanjin Watermelon Frost products, reflecting the company's strong market presence and consumer trust built over decades [7]. - The company maintains a comprehensive cost control system across its production processes, allowing it to offer high-quality products at competitive prices [7]. Group 3: Innovation-Driven Development - During the 14th Five-Year Plan, Guilin Sanjin has focused on innovation, establishing a joint innovation platform for traditional Chinese medicine and actively participating in national and regional research projects [9][10]. - The company has made significant advancements in its product lines, with multiple iterations of existing products to enhance efficacy and adapt to market needs [10][11]. - In the biopharmaceutical sector, Guilin Sanjin's subsidiary, Baoshan Biotech, is developing innovative drugs for autoimmune diseases and has received clinical approvals for several products [10][11]. Group 4: Supply Chain and Distribution - Guilin Sanjin employs a competitive bidding process for sourcing raw materials, ensuring quality and cost-effectiveness in its supply chain [12]. - The company has established a robust distribution network with nearly 100 main distributors and over a thousand sub-distributors, facilitating widespread market access [12]. - Currently, 18 of the company's products are registered and sold in 17 countries and regions, enhancing its international presence [13].

Core Viewpoint - Guilin Sanjin is leveraging traditional craftsmanship and innovative strategies to enhance product quality and drive growth during the 14th Five-Year Plan period [3][10]. Group 1: Product Innovation and Heritage - The company's flagship product, Sanjin Watermelon Frost, has a history of over 200 years and has been modernized through innovative production techniques that ensure high purity and effectiveness while reducing production time and environmental impact [3][4]. - Guilin Sanjin's commitment to traditional techniques has led to the successful inclusion of "Guilin Sanjin Watermelon Frost Production Technique" in the Guilin Intangible Cultural Heritage list in 2024, affirming the company's role in preserving and revitalizing traditional Chinese medicine [3][10]. Group 2: Market Strategy and Consumer Focus - The company adopts a "thin profit margin, high sales volume" strategy, ensuring affordable pricing for its products, which are widely available in over 90% of pharmacies across China [6][10]. - Sanjin Watermelon Frost and Sanjin Tablets have been market leaders for over 30 years, achieving a stable market share due to their consistent efficacy and consumer trust [6][10]. Group 3: Research and Development - During the 14th Five-Year Plan, Guilin Sanjin has received multiple awards for its research projects, highlighting its strong capabilities in scientific innovation [5][10]. - The company is actively involved in the development of innovative drugs and has made significant improvements to existing products, with Sanjin Watermelon Frost undergoing eight rounds of innovation [8][9]. Group 4: Supply Chain and Distribution - Guilin Sanjin maintains a robust supply chain with long-term relationships with suppliers, ensuring a steady supply of key raw materials for its products [10]. - The company has established a mature distribution network with nearly 100 main distributors and over 2,000 chain pharmacies, facilitating its market reach [10]. Group 5: International Expansion - Guilin Sanjin has successfully registered and launched 18 products in 17 countries and regions, expanding its presence in markets along the Belt and Road Initiative [10].